Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aeee8d3f65d495ab7c77f7132d3b5da2 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10322 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-861 |
filingDate |
1997-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2000-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ed626a7cb6cf9666fba503989eb655d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6b6e716e1d3036d0cd6f1e0448b44dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28adb7781fb288158bba819ca0b61d18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b2bce17001ce38d606f6ad321b4dcb8 |
publicationDate |
2000-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-6086890-A |
titleOfInvention |
Bovine adenovirus expression vector system |
abstract |
The present invention relates novel live bovine adenovirus (BAV) expression vector systems in which part or all of one or both of the early region 1 (E1) and early region 3 (E3) genes are deleted and replaced by a foreign gene or fragment thereof and novel recombinant mammalian cell lines stably transformed with BAV E1 sequences, and therefore, express E1 gene products capable of allowing replication therein of a bovine adenovirus having an E1 deletion replaced by a heterologous nucleotide sequence encoding a foreign gene or fragment thereof and their use in production of (antigenic) polypeptides or fragments thereof for the purpose of live recombinant virus or subunit vaccine or for other therapies. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7264818-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6451319-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007082010-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11180764-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7666993-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005276758-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10525127-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7025967-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005266530-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7342107-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015284729-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003106098-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019298823-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005129713-A1 |
priorityDate |
1993-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |